HER2 synNotch/CEA-CAR 组合免疫治疗针对 HER2 扩增结直肠癌的临床前疗效
Preclinical efficacy of a HER2 synNotch/CEA-CAR combinatorial immunotherapy against colorectal cancer with HER2 amplification.
64.0分
★★★☆☆
站内排序·非疗效
ALL SOURCES
MEMBER ACCOUNT
登录成功会直接打开下一页。